Published by
The Street
The Street
By PR Newswire GREENSBORO, N.C., Jan. 4, 2022 /PRNewswire/ — URO-1 Inc., www.uro1medical.com, an innovator of medical devices for urology and urogynecology, today announced achievement of multiple milestones toward commercializing its breakthrough products for prostate biopsy and other procedures. The company has reached its goal to raise $5.0M in Series A financing, which was originally led by Acorn Campus of Taiwan, following a recent sizeable investment by angel investors from Tennessee and Kentucky. It also announced positive results from initial clinical studies of its FDA-cleared SUREco…